[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339932-105":59,"doc-detail-339932-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluation-of-sodium-borocaptate-bsh-and-boronophenylalanine-bpa-as-boron-delivery-agents-for-neutron-capture-therapy-nct-of-cancer-an-update-and-a-guide-for-the-future-clinical-evaluation-of-new-boron-delivery-agents","Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer - an update and a guide for the future clinical evaluation of new boron delivery agents","","Boron neutron capture therapy (BNCT) is a cancer treatment based on nuclear capture and fission reactions triggered when boron-10 is irradiated with appropriately energized neutrons to generate boron-11, leading to instantaneous fission and tumoricidal alpha particles. This review updates clinical evaluation pathways for sodium borocaptate (BSH) and boronophenylalanine (BPA), summarizing foundational pharmacokinetic, pharmacodynamic, and biodistribution studies. It consolidates Japanese and additional institutional findings from initial patient studies in high-grade gliomas and addresses future clinical assessment requirements for emerging boron delivery agents.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-sodium-borocaptate-bsh-and-boronophenylalanine-bpa-as-boron-delivery-agents-for-neutron-capture-therapy-nct-of-cancer-an-update-and-a-guide-for-the-future-clinical-evaluation-of-new-boron-delivery-agents/339932/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-sodium-borocaptate-bsh-and-boronophenylalanine-bpa-as-boron-delivery-agents-for-neutron-capture-therapy-nct-of-cancer-an-update-and-a-guide-for-the-future-clinical-evaluation-of-new-boron-delivery-agents/339932.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the therapeutic mechanism of BNCT described in the review?","Question",{"text":112,"@type":113},"BNCT relies on neutron capture by boron-10 to form boron-11, which undergoes instantaneous nuclear fission. This generates high-energy alpha particles and other recoiling nuclei with tumoricidal effect.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which two clinically used boron delivery agents are the focus of this review?",{"text":117,"@type":113},"The review focuses on sodium borocaptate (BSH) and boronophenylalanine (BPA). It discusses their initial clinical use and subsequent roles as BNCT boron delivery agents.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main purpose regarding future evaluation of new boron delivery agents?",{"text":121,"@type":113},"The review provides a guide for future clinical evaluation of new boron delivery agents before their use in BNCT. It notes that despite efforts to develop better agents, none have yet been evaluated clinically.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339932,1790555905,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","DOI: 10.1002/cac2.12582  \nREVIEW  \nEvaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT  \nRolf F. Barth1  Nilendu Gupta2   Shinji Kawabata3  \n1 Department of Pathology, The Ohio State University, Columbus, Ohio, USA  \n2 Department of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA  \n3 Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan  \nCorrespondence  \nNilendu Gupta, Department of Radiation Oncology, The Ohio State University, Columbus, Ohio 43210, USA. [Email:](Email: nilendu.gupta@osumc.edu)[ nilendu.gupta@osumc.edu](Email: nilendu.gupta@osumc.edu)  \nAbstract  \nBoron neutron capture therapy (BNCT) is a cancer treatment modality based on the nuclear capture and fission reactions that occur when boron-10, a stable isotope, is irradiated with neutrons of the appropriate energy to produce boron-11 in an unstable form, which undergoes instantaneous nuclear fission to produce high-energy, tumoricidal alpha particles. The primary purpose of this review is to provide an update on the first drug used clinically, sodium borocaptate (BSH), by the Japanese neurosurgeon Hiroshi Hatanaka to treat patients with brain tumors and the second drug, boronophenylalanine (BPA), which first was used clinically by the Japanese dermatologist Yutaka Mishima to treat patients with cutaneous melanomas. Subsequently, BPA has become the primary drug used as a boron delivery agent to treat patients with several types of cancers, specifically brain tumors and recurrent tumors ofthe head and neck region. The focus of this review will be on the initial studies that were carried out to define the pharmacokinetics and pharmacodynamics of BSH and BPA and their biodistribution in tumor and normal tissues following administration to patients with high-grade gliomas and their subsequent clinical use to treat patients with highgrade gliomas. First, we will summarize the studies that were carried out in Japan with BSH and subsequently at our own institution, The Ohio State University, and those of several other groups. Second, we will describe studies carried out in Japan with BPA and then in the United States that have led to its use as the  \nList of Abbreviations: AA, Anaplastic astrocytoma; ABNS, Accelerator-based neutron source; BBB, Blood brain barrier; BMRR, Brookhaven Medical Research Reactor; BNCT, Boron Neutron Capture Therapy; BPA, Boronophenylalanine, a di-hydroxyl boryl derivative of phenylalanine; BSH, Sodium Borocaptate or di-sodium undecahydro-mercapto-closo-dodecoborate; DCP-AES, Direct Current Plasma – Atomic Emission Spectroscopy; EORTC, European Organization for Research and Treatment of Cancer; FDA, US Food and Drug Administration; GBM, Glioblastoma multiforme; KURRI, Kyoto University Research Reactor Institute; LAT1, L-type aminoacid transporter-1; LET, Linear Energy Transfer; MST, Mean survival time; OSU, The Ohio State University; PDT, Photodynamic therapy; ppm, Parts per million; T1/2 , Half life; TMZ, Temazolomide; XRT, External Beam radiation therapy.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Author(s) . Cancer Communications published by John Wiley & Sons Australia, Ltd on behalf of Sun Yat-sen University Cancer Center.  \nBARTH et al.  \nprimary drug that is being used clinically for BNCT. Third, although there have been intense efforts to develop new and better boron delivery agents for BNCT, none of these have yet been evaluated clinically. The present report will provide a guide to the future clinical evaluation of new boron delivery agents prio","cbCaicFrsCu49gl2","https://ap.wps.com/l/cbCaicFrsCu49gl2","pdf",639922,17,"English","# Abstract\n# List of Abbreviations\n# Keywords\n# 1 Background","[{\"question\":\"What is the therapeutic mechanism of BNCT described in the review?\",\"answer\":\"BNCT relies on neutron capture by boron-10 to form boron-11, which undergoes instantaneous nuclear fission. This generates high-energy alpha particles and other recoiling nuclei with tumoricidal effect.\"},{\"question\":\"Which two clinically used boron delivery agents are the focus of this review?\",\"answer\":\"The review focuses on sodium borocaptate (BSH) and boronophenylalanine (BPA). It discusses their initial clinical use and subsequent roles as BNCT boron delivery agents.\"},{\"question\":\"What is the main purpose regarding future evaluation of new boron delivery agents?\",\"answer\":\"The review provides a guide for future clinical evaluation of new boron delivery agents before their use in BNCT. It notes that despite efforts to develop better agents, none have yet been evaluated clinically.\"}]","Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer - an update and a guide for the future clinical evaluation of new boron delivery agents | PDF",1790033168,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5624682cb3045d0aaa2cd854cbdf0f5a.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b12d6ea2ed9a02b0de78410ca2e6f9b7.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfffa86eedb8431579a19a4b19bed12c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1adb49d1e59a65609b22fe61939a2b27.webp",980,1287]